{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:16:28Z","timestamp":1794975388897,"version":"4.9.1"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD), the most common dementia in the elderly, is marked by progressive cognitive decline and neurodegeneration. Core pathological hallmarks include amyloid-beta (A\u03b2) plaques, hyperphosphorylated tau aggregates, neuroinflammation, and metabolic dysfunction (e.g., impaired glucose utilization, mitochondrial deficits). Apolipoprotein E4 (ApoE4), the strongest genetic risk factor for AD, interacts with these processes, yet its precise pathogenic mechanisms remain unclear. This review examines ApoE4\u2019s multifaceted contributions to AD pathogenesis, focusing on its roles in A\u03b2 accumulation, tau hyperphosphorylation, neuroinflammatory activation, and metabolic dysregulation. We further evaluate emerging therapeutic strategies targeting these pathways, including ApoE4 modulation, anti-amyloid\/tau interventions, and metabolic rescue approaches. Elucidating the molecular interplay between ApoE4 and AD pathology is critical for developing targeted therapies to modify disease progression and mitigate cognitive decline in patients.<\/jats:p>","DOI":"10.1038\/s41420-025-02600-y","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:33:38Z","timestamp":1751934818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["The multifaceted roles of apolipoprotein E4 in Alzheimer\u2019s disease pathology and potential therapeutic strategies"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4488-0380","authenticated-orcid":false,"given":"Yongfeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3395-640X","authenticated-orcid":false,"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7133-8875","authenticated-orcid":false,"given":"Mihnea-Alexandru","family":"G\u0103man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3494-9532","authenticated-orcid":false,"given":"Zhenyou","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2600_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25:91\u2013110.","journal-title":"Nat Rev Neurosci"},{"key":"2600_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani AR, Affaneh A, Van Gulden S, Kessler JA. Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease. Ann Neurol. 2019;85:726\u201339.","journal-title":"Ann Neurol"},{"key":"2600_CR3","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","volume":"25","author":"CC Liu","year":"2022","unstructured":"Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, et al. Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci. 2022;25:1020\u201333.","journal-title":"Nat Neurosci"},{"key":"2600_CR4","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/febs.15075","volume":"287","author":"T Islam","year":"2020","unstructured":"Islam T, Gharibyan AL, Golchin SA, Pettersson N, Br\u00e4nnstr\u00f6m K, Hedberg I, et al. Apolipoprotein E impairs amyloid-\u03b2 fibril elongation and maturation. FEBS J. 2020;287:1208\u201319.","journal-title":"FEBS J"},{"key":"2600_CR5","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/glia.23974","volume":"69","author":"MF Lanfranco","year":"2021","unstructured":"Lanfranco MF, Sepulveda J, Kopetsky G, Rebeck GW. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia. 2021;69:1478\u201393.","journal-title":"Glia"},{"key":"2600_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112196","volume":"42","author":"S Lee","year":"2023","unstructured":"Lee S, Devanney NA, Golden LR, Smith CT, Schwartz JL, Walsh AE, et al. APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep. 2023;42:112196.","journal-title":"Cell Rep"},{"key":"2600_CR7","doi-asserted-by":"publisher","first-page":"19926","DOI":"10.1073\/pnas.2002570117","volume":"117","author":"D Chakraborty","year":"2020","unstructured":"Chakraborty D, Straub JE, Thirumalai D. Differences in the free energies between the excited states of A\u03b240 and A\u03b242 monomers encode their aggregation propensities. Proc Natl Acad Sci USA. 2020;117:19926\u201337.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2600_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-022-01332-9","volume":"10","author":"N Salvadores","year":"2022","unstructured":"Salvadores N, Moreno-Gonzalez I, Gamez N, Quiroz G, Vegas-Gomez L, Escand\u00f3n M, et al. A\u03b2 oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2022;10:31.","journal-title":"Acta Neuropathol Commun"},{"key":"2600_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2021.158980","volume":"1866","author":"AB Chai","year":"2021","unstructured":"Chai AB, Lam HHJ, Kockx M, Gelissen IC. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer\u2019s amyloid-\u03b2. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866:158980.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2600_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang YA, Zhou B, Wernig M, S\u00fcdhof TC. ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion. Cell. 2017;168:427\u201341.e21.","journal-title":"Cell"},{"key":"2600_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2021.102212","volume":"209","author":"ZH Wang","year":"2022","unstructured":"Wang ZH, Xia Y, Wu Z, Kang SS, Zhang JC, Liu P, et al. Neuronal ApoE4 stimulates C\/EBP\u03b2 activation, promoting Alzheimer\u2019s disease pathology in a mouse model. Prog Neurobiol. 2022;209:102212.","journal-title":"Prog Neurobiol"},{"key":"2600_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fnagi.2015.00207","volume":"7","author":"X Hou","year":"2015","unstructured":"Hou X, Adeosun SO, Zhang Q, Barlow B, Brents M, Zheng B, et al. Differential contributions of ApoE4 and female sex to BACE1 activity and expression mediate A\u03b2 deposition and learning and memory in mouse models of Alzheimer\u2019s disease. Front Aging Neurosci. 2015;7:207.","journal-title":"Front Aging Neurosci"},{"key":"2600_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/hmg\/ddt451","volume":"23","author":"A Iwata","year":"2014","unstructured":"Iwata A, Nagata K, Hatsuta H, Takuma H, Bundo M, Iwamoto K, et al. Altered CpG methylation in sporadic Alzheimer\u2019s disease is associated with APP and MAPT dysregulation. Hum Mol Genet. 2014;23:648\u201356.","journal-title":"Hum Mol Genet"},{"key":"2600_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13470","volume":"16","author":"Y Gao","year":"2024","unstructured":"Gao Y, Yu H, Liu Y, Xu Z, He B, Liu H, et al. GSK-3\u03b2 activation mediates apolipoprotein E4-associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross-sectional study. J Diab. 2024;16:e13470.","journal-title":"J Diab"},{"key":"2600_CR15","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.neuron.2023.03.024","volume":"111","author":"X Hou","year":"2023","unstructured":"Hou X, Zhang X, Zou H, Guan M, Fu C, Wang W, et al. Differential and substrate-specific inhibition of \u03b3-secretase by the C-terminal region of ApoE2, ApoE3, and ApoE4. Neuron. 2023;111:1898\u2013913.e5.","journal-title":"Neuron"},{"key":"2600_CR16","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.stemcr.2021.07.017","volume":"16","author":"SI Lee","year":"2021","unstructured":"Lee SI, Jeong W, Lim H, Cho S, Lee H, Jang Y, et al. APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and A\u03b2 generation. Stem Cell Rep. 2021;16:2128\u201337.","journal-title":"Stem Cell Rep"},{"key":"2600_CR17","doi-asserted-by":"publisher","first-page":"e2102191118","DOI":"10.1073\/pnas.2102191118","volume":"118","author":"H Wang","year":"2021","unstructured":"Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proc Natl Acad Sci USA. 2021;118:e2102191118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2600_CR18","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1096\/fj.201700359","volume":"31","author":"RA Nixon","year":"2017","unstructured":"Nixon RA. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease. FASEB J. 2017;31:2729\u201343.","journal-title":"FASEB J"},{"key":"2600_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/27694127.2022.2040767","volume":"1","author":"GM Fote","year":"2022","unstructured":"Fote GM, Steffan JS. APOE4 dysregulates autophagy in cultured cells. Autophagy Rep. 2022;1:29\u201333.","journal-title":"Autophagy Rep"},{"key":"2600_CR20","doi-asserted-by":"crossref","unstructured":"Krogsaeter EK, McKetney J, Valiente-Banuet L, Marquez A, Willis A, Cakir Z, et al. Lysosomal proteomics reveals mechanisms of neuronal apoE4-associated lysosomal dysfunction. bioRxiv. 2025;2023.10.02.560519.","DOI":"10.1101\/2023.10.02.560519"},{"key":"2600_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2021.102032","volume":"202","author":"ZH Wang","year":"2021","unstructured":"Wang ZH, Xia Y, Liu P, Liu X, Edgington-Mitchell L, Lei K, et al. ApoE4 activates C\/EBP\u03b2\/\u03b4-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer\u2019s disease. Prog Neurobiol. 2021;202:102032.","journal-title":"Prog Neurobiol"},{"key":"2600_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7760","volume":"6","author":"S Ayton","year":"2015","unstructured":"Ayton S, Faux NG, Bush AI. Alzheimer\u2019s Disease Neuroimaging Initiative. Ferritin levels in the cerebrospinal fluid predict Alzheimer\u2019s disease outcomes and are regulated by APOE. Nat Commun. 2015;6:6760.","journal-title":"Nat Commun"},{"key":"2600_CR23","doi-asserted-by":"publisher","first-page":"11148","DOI":"10.18632\/aging.102516","volume":"11","author":"J Yin","year":"2019","unstructured":"Yin J, Nielsen M, Carcione T, Li S, Shi J. Apolipoprotein E regulates mitochondrial function through the PGC-1\u03b1-sirtuin 3 pathway. Aging (Albany NY). 2019;11:11148\u201356.","journal-title":"Aging (Albany NY)"},{"key":"2600_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70306","volume":"31","author":"P Wei","year":"2025","unstructured":"Wei P, Lin K, Chen X, Fang C, Qiu L, Hu J, et al. Sequential proteomic analysis reveals the key APOE4-induced pathological and molecular features at the presymptomatic stage in Alzheimer\u2019s disease mice. CNS Neurosci Ther. 2025;31:e70306.","journal-title":"CNS Neurosci Ther"},{"key":"2600_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","volume":"6","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Bu G. The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:93.","journal-title":"Front Aging Neurosci"},{"key":"2600_CR26","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","volume":"65","author":"JS Miners","year":"2006","unstructured":"Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2006;65:1012\u201321.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2600_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, et al. ApoE promotes the proteolytic degradation of Abeta. Neuron. 2008;58:681\u201393.","journal-title":"Neuron"},{"key":"2600_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-150348","volume":"48","author":"JT Keeney","year":"2015","unstructured":"Keeney JT, Ibrahimi S, Zhao L. Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer\u2019s disease prevention and early intervention. J Alzheimers Dis. 2015;48:411\u201324.","journal-title":"J Alzheimers Dis"},{"key":"2600_CR29","doi-asserted-by":"publisher","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","volume":"24","author":"L Zhao","year":"2004","unstructured":"Zhao L, Teter B, Morihara T, Lim GP, Ambegaokar SS, Ubeda OJ, et al. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer\u2019s disease intervention. J Neurosci. 2004;24:11120\u20136.","journal-title":"J Neurosci"},{"key":"2600_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2009.07.032","volume":"464","author":"J Du","year":"2009","unstructured":"Du J, Chang J, Guo S, Zhang Q, Wang Z. ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons. Neurosci Lett. 2009;464:140\u20135.","journal-title":"Neurosci Lett"},{"key":"2600_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577315","volume":"346","author":"D Graykowski","year":"2020","unstructured":"Graykowski D, Kasparian K, Caniglia J, Gritsaeva Y, Cudaback E. Neuroinflammation drives APOE genotype-dependent differential expression of neprilysin. J Neuroimmunol. 2020;346:577315.","journal-title":"J Neuroimmunol"},{"key":"2600_CR32","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, et al. ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions. Proc Natl Acad Sci USA. 2013;110:E1807\u201316.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2600_CR33","unstructured":"Joshi SS. Rescuing the Secretion and Lipidation Deficits of APOE4 Using HDL Mimetic Peptides in Primary Glial Cells. University of Minnesota (2023)."},{"key":"2600_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s42003-024-05767-9","volume":"7","author":"M Balasubramaniam","year":"2024","unstructured":"Balasubramaniam M, Narasimhappagari J, Liu L, Ganne A, Ayyadevara S, Atluri R, et al. Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer\u2019s disease by targeted small molecules. Commun Biol. 2024;7:60.","journal-title":"Commun Biol"},{"key":"2600_CR35","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.258687","volume":"135","author":"GM Fote","year":"2022","unstructured":"Fote GM, Geller NR, Efstathiou NE, Hendricks N, Vavvas DG, Reidling JC, et al. Isoform-dependent lysosomal degradation and internalization of apolipoprotein E requires autophagy proteins. J Cell Sci. 2022;135:jcs258687.","journal-title":"J Cell Sci"},{"key":"2600_CR36","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","volume":"287","author":"CY Lee","year":"2012","unstructured":"Lee CY, Tse W, Smith JD, Landreth GE. Apolipoprotein E promotes \u03b2-amyloid trafficking and degradation by modulating microglial cholesterol levels. J Biol Chem. 2012;287:2032\u201344.","journal-title":"J Biol Chem"},{"key":"2600_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4172\/2155-9562.1000236","volume":"5","author":"X Chen","year":"2014","unstructured":"Chen X, Hui L, Geiger JD. Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer\u2019s disease. J Neurol Neurophysiol. 2014;5:236.","journal-title":"J Neurol Neurophysiol"},{"key":"2600_CR38","first-page":"e041293","volume":"16","author":"M Fiala","year":"2020","unstructured":"Fiala M. Omega-3 fatty acid add-on nutritional immunotherapy delays progression to dementia in MCI patients on cholinesterase therapy: Human\/Human trials: Nutraceuticals and non-pharmacological interventions. Alzheimer\u2019s & dementia. Dementia. 2020;16:e041293.","journal-title":"Dementia"},{"key":"2600_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","volume":"30","author":"SH Baik","year":"2019","unstructured":"Baik SH, Kang S, Lee W, Choi H, Chung S, Kim JI, et al. A Breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer\u2019s disease. Cell Metab. 2019;30:493\u2013507.e6.","journal-title":"Cell Metab"},{"key":"2600_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2022;79:13\u201321.","journal-title":"JAMA Neurol"},{"key":"2600_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1169499","volume":"15","author":"Y Qiao","year":"2023","unstructured":"Qiao Y, Chi Y, Zhang Q, Ma Y. Safety and efficacy of lecanemab for Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized clinical trials. Front Aging Neurosci. 2023;15:1169499.","journal-title":"Front Aging Neurosci"},{"key":"2600_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.862369","volume":"13","author":"CG Withington","year":"2022","unstructured":"Withington CG, Turner RS. Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer\u2019s disease. Front Neurol. 2022;13:862369.","journal-title":"Front Neurol"},{"key":"2600_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-023-00610-x","volume":"18","author":"M Xiong","year":"2023","unstructured":"Xiong M, Wang C, Gratuze M, Saadi F, Bao X, Bosch ME, et al. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy. Mol Neurodegener. 2023;18:17.","journal-title":"Mol Neurodegener"},{"key":"2600_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd7522","volume":"13","author":"M Xiong","year":"2021","unstructured":"Xiong M, Jiang H, Serrano JR, Gonzales ER, Wang C, Gratuze M, et al. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Transl Med. 2021;13:eabd7522.","journal-title":"Sci Transl Med"},{"key":"2600_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1749-6632.2000.tb06366.x","volume":"903","author":"MO McCarron","year":"2000","unstructured":"McCarron MO, Nicoll JA. Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage. Ann N Y Acad Sci. 2000;903:176\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"2600_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00401-004-0890-7","volume":"108","author":"B Mazur-Kolecka","year":"2004","unstructured":"Mazur-Kolecka B, Kowal D, Sukontasup T, Dickson D, Frackowiak J. The effect of oxidative stress on amyloid precursor protein processing in cells engaged in beta-amyloidosis is related to apolipoprotein E genotype. Acta Neuropathol. 2004;108:287\u201394.","journal-title":"Acta Neuropathol"},{"key":"2600_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17:5\u201321.","journal-title":"Nat Rev Neurosci"},{"key":"2600_CR48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2015.02.028","volume":"83","author":"A Lloret","year":"2015","unstructured":"Lloret A, Fuchsberger T, Giraldo E, Vi\u00f1a J. Molecular mechanisms linking amyloid \u03b2 toxicity and Tau hyperphosphorylation in Alzheimer\u05f3s disease. Free Radic Biol Med. 2015;83:186\u201391.","journal-title":"Free Radic Biol Med"},{"key":"2600_CR49","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, Najm R, Xu Q, Jeong DE, Walker D, Balestra ME, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018;24:647\u201357.","journal-title":"Nat Med"},{"key":"2600_CR50","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523\u20137.","journal-title":"Nature"},{"key":"2600_CR51","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109:1657\u201374.e7.","journal-title":"Neuron"},{"key":"2600_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","volume":"3","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris N, Blumenfeld J, Agrawal A, Traglia M, Grone B, Zilberter M, et al. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nat Aging. 2023;3:275\u201396.","journal-title":"Nat Aging"},{"key":"2600_CR53","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2174\/1567205013666160415154550","volume":"13","author":"M Zhou","year":"2016","unstructured":"Zhou M, Huang T, Collins N, Zhang J, Shen H, Dai X, et al. APOE4 induces site-specific tau phosphorylation through calpain-CDK5 signaling pathway in EFAD-Tg mice. Curr Alzheimer Res. 2016;13:1048\u201355.","journal-title":"Curr Alzheimer Res"},{"key":"2600_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166793","volume":"1869","author":"R Piccarducci","year":"2023","unstructured":"Piccarducci R, Giacomelli C, Bertilacchi MS, Benito-Martinez A, Di Giorgi N, Daniele S, et al. Apolipoprotein E \u03b54 triggers neurotoxicity via cholesterol accumulation, acetylcholine dyshomeostasis, and PKC\u03b5 mislocalization in cholinergic neuronal cells. Biochim Biophys Acta Mol Basis Dis. 2023;1869:166793.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2600_CR55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1567205016666190228120254","volume":"16","author":"S Salomon-Zimri","year":"2019","unstructured":"Salomon-Zimri S, Koren A, Angel A, Ben-Zur T, Offen D, Michaelson DM. The role of MAPK\u2019s signaling in mediating ApoE4-driven pathology in vivo. Curr Alzheimer Res. 2019;16:281\u201392.","journal-title":"Curr Alzheimer Res"},{"key":"2600_CR56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mcn.2017.07.002","volume":"83","author":"V Theendakara","year":"2017","unstructured":"Theendakara V, Bredesen DE, Rao RV. Downregulation of protein phosphatase 2A by apolipoprotein E: implications for Alzheimer\u2019s disease. Mol Cell Neurosci. 2017;83:83\u201391.","journal-title":"Mol Cell Neurosci"},{"key":"2600_CR57","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1523\/JNEUROSCI.3562-15.2016","volume":"36","author":"V Theendakara","year":"2016","unstructured":"Theendakara V, Peters-Libeu CA, Spilman P, Poksay KS, Bredesen DE, Rao RV. Direct transcriptional effects of apolipoprotein E. J Neurosci. 2016;36:685\u2013700.","journal-title":"J Neurosci"},{"key":"2600_CR58","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi Y, Manis M, Long J, Wang K, Sullivan PM, Remolina Serrano J, et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med. 2019;216:2546\u201361.","journal-title":"J Exp Med"},{"key":"2600_CR59","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","volume":"33","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA, et al. Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model. J Neurosci. 2013;33:5053\u201364.","journal-title":"J Neurosci"},{"key":"2600_CR60","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.3390\/cells11223616","volume":"11","author":"AN Lazar","year":"2022","unstructured":"Lazar AN, Hanbouch L, Boussicaut L, Fourmaux B, Daira P, Millan MJ, et al. Lipid dys-homeostasis contributes to APOE4-associated AD pathology. Cells. 2022;11:3616.","journal-title":"Cells"},{"key":"2600_CR61","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1007\/s12035-023-03886-8","volume":"61","author":"VM Garc\u00eda-Cruz","year":"2024","unstructured":"Garc\u00eda-Cruz VM, Arias C. Palmitic acid induces posttranslational modifications of tau protein in Alzheimer\u2019s disease-related epitopes and increases intraneuronal tau levels. Mol Neurobiol. 2024;61:5129\u201341.","journal-title":"Mol Neurobiol"},{"key":"2600_CR62","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.bbamcr.2014.04.004","volume":"1843","author":"B Kwon","year":"2014","unstructured":"Kwon B, Lee HK, Querfurth HW. Oleate prevents palmitate-induced mitochondrial dysfunction, insulin resistance and inflammatory signaling in neuronal cells. Biochim Biophys Acta. 2014;1843:1402\u201313.","journal-title":"Biochim Biophys Acta"},{"key":"2600_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105260","volume":"153","author":"TY Wu","year":"2022","unstructured":"Wu TY, Zhao LX, Zhang YH, Fan YG. Activation of vitamin D receptor inhibits Tau phosphorylation is associated with reduction of iron accumulation in APP\/PS1 transgenic mice. Neurochem Int. 2022;153:105260.","journal-title":"Neurochem Int"},{"key":"2600_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14541","volume":"21","author":"MA Thorwald","year":"2025","unstructured":"Thorwald MA, Godoy-Lugo JA, Garcia G, Silva J, Kim M, Christensen A, et al. Iron-associated lipid peroxidation in Alzheimer\u2019s disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in mice. Alzheimers Dement. 2025;21:e14541.","journal-title":"Alzheimers Dement"},{"key":"2600_CR65","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/ijms24010778","volume":"24","author":"M Pires","year":"2023","unstructured":"Pires M, Rego AC. Apoe4 and Alzheimer\u2019s disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies. Int J Mol Sci. 2023;24:778.","journal-title":"Int J Mol Sci"},{"key":"2600_CR66","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/antiox11081421","volume":"11","author":"F Bartolome","year":"2022","unstructured":"Bartolome F, Carro E, Alquezar C. Oxidative stress in tauopathies: from cause to therapy. Antioxid (Basel). 2022;11:1421.","journal-title":"Antioxid (Basel)"},{"key":"2600_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.toxlet.2017.07.892","volume":"279","author":"SW Kang","year":"2017","unstructured":"Kang SW, Kim SJ, Kim MS. Oxidative stress with tau hyperphosphorylation in memory impaired 1,2-diacetylbenzene-treated mice. Toxicol Lett. 2017;279:53\u20139.","journal-title":"Toxicol Lett"},{"key":"2600_CR68","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1021\/acschemneuro.3c00341","volume":"14","author":"D Saha","year":"2023","unstructured":"Saha D, Paul S, Gaharwar U, Priya A, Neog A, Singh A, et al. Cdk5-mediated brain unfolded protein response upregulation associated with cognitive impairments in type 2 diabetes and ameliorative action of NAC. ACS Chem Neurosci. 2023;14:2761\u201374.","journal-title":"ACS Chem Neurosci"},{"key":"2600_CR69","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1515\/revneuro-2017-0013","volume":"28","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Chen X, Zhao Y, Ponnusamy M, Liu Y. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer\u2019s disease. Rev Neurosci. 2017;28:861\u20138.","journal-title":"Rev Neurosci"},{"key":"2600_CR70","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3233\/JAD-150738","volume":"56","author":"T Persson","year":"2017","unstructured":"Persson T, Lattanzio F, Calvo-Garrido J, Rimondini R, Rubio-Rodrigo M, Sundstr\u00f6m E, et al. Apolipoprotein E4 elicits lysosomal cathepsin D release, decreased thioredoxin-1 levels, and apoptosis. J Alzheimers Dis. 2017;56:601\u201317.","journal-title":"J Alzheimers Dis"},{"key":"2600_CR71","unstructured":"Huang S. Evaluate the Therapeutic Efficacy of Lysosome Re-acidification by Tetrandrine on Tauopathy Models. Hong Kong Baptist University (2023)."},{"key":"2600_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41545-7","volume":"14","author":"I Maniv","year":"2023","unstructured":"Maniv I, Sarji M, Bdarneh A, Feldman A, Ankawa R, Koren E, et al. Altered ubiquitin signaling induces Alzheimer\u2019s disease-like hallmarks in a three-dimensional human neural cell culture model. Nat Commun. 2023;14:5922.","journal-title":"Nat Commun"},{"key":"2600_CR73","doi-asserted-by":"publisher","unstructured":"Paradise V, Sabu M, Bafia J, et al. ApoE isoforms differentially regulate neuronal membrane proteasomes to shift the threshold for pathological aggregation of endogenous Tau. Biorxiv https:\/\/doi.org\/10.1101\/2022.11.29.518293 (2022).","DOI":"10.1101\/2022.11.29.518293"},{"key":"2600_CR74","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, Luna G, Guzman E, Audouard M, Challis C, Sibih YE, et al. LRP1 is a master regulator of tau uptake and spread. Nature. 2020;580:381\u20135.","journal-title":"Nature"},{"key":"2600_CR75","doi-asserted-by":"publisher","first-page":"e2108870119","DOI":"10.1073\/pnas.2108870119","volume":"119","author":"SR Saroja","year":"2022","unstructured":"Saroja SR, Gorbachev K, Julia T, Goate AM, Pereira AC. Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation. Proc Natl Acad Sci USA. 2022;119:e2108870119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2600_CR76","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3233\/JAD-230514","volume":"97","author":"M Safieh","year":"2024","unstructured":"Safieh M, Liraz O, Ovadia M, Michaelson D. The role of impaired receptor trafficking in mediating the pathological effects of APOE4 in Alzheimer\u2019s disease. J Alzheimers Dis. 2024;97:753\u201375.","journal-title":"J Alzheimers Dis"},{"key":"2600_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100715","volume":"296","author":"JM Cooper","year":"2021","unstructured":"Cooper JM, Lathuiliere A, Migliorini M, Arai AL, Wani MM, Dujardin S, et al. Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism. J Biol Chem. 2021;296:100715.","journal-title":"J Biol Chem"},{"key":"2600_CR78","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","volume":"388","author":"S Gauthier","year":"2016","unstructured":"Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet. 2016;388:2873\u201384.","journal-title":"Lancet"},{"key":"2600_CR79","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41582-021-00483-y","volume":"17","author":"P Hasel","year":"2021","unstructured":"Hasel P, Liddelow SA. Isoform-dependent APOE secretion modulates neuroinflammation. Nat Rev Neurol. 2021;17:265\u20136.","journal-title":"Nat Rev Neurol"},{"key":"2600_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation. 2022;19:206.","journal-title":"J Neuroinflammation"},{"key":"2600_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101594","volume":"59","author":"S Parhizkar","year":"2022","unstructured":"Parhizkar S, Holtzman DM. APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Semin Immunol. 2022;59:101594.","journal-title":"Semin Immunol"},{"key":"2600_CR82","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, et al. Microglial activation and tau propagate jointly across Braak stages. Nat Med. 2021;27:1592\u20139.","journal-title":"Nat Med"},{"key":"2600_CR83","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade1474","volume":"9","author":"JP Ferrari-Souza","year":"2023","unstructured":"Ferrari-Souza JP, Lussier FZ, Leffa DT, Therriault J, Tissot C, Bellaver B, et al. APOE\u03b54 associates with microglial activation independently of A\u03b2 plaques and tau tangles. Sci Adv. 2023;9:eade1474.","journal-title":"Sci Adv"},{"key":"2600_CR84","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Nwabuisi-Heath E, Dumanis SB, Tai LM, Yu C, Rebeck GW, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 2012;60:559\u201369.","journal-title":"Glia"},{"key":"2600_CR85","first-page":"30","volume":"5","author":"L Bouchareychas","year":"2018","unstructured":"Bouchareychas L, Raffai RL. Apolipoprotein E and Atherosclerosis: from Lipoprotein Metabolism to MicroRNA control of inflammation. J Cardiovasc Dev Dis. 2018;5:30.","journal-title":"J Cardiovasc Dev Dis"},{"key":"2600_CR86","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023;615:668\u201377.","journal-title":"Nature"},{"key":"2600_CR87","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neulet.2014.10.016","volume":"584","author":"J Park","year":"2015","unstructured":"Park J, Min JS, Kim B, Chae UB, Yun JW, Choi MS, et al. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-\u03baB pathways. Neurosci Lett. 2015;584:191\u20136.","journal-title":"Neurosci Lett"},{"key":"2600_CR88","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12427","volume":"51","author":"S Jiang","year":"2018","unstructured":"Jiang S, Zhao Y, Zhang T, Lan J, Yang J, Yuan L, et al. Galantamine inhibits \u03b2-amyloid-induced cytostatic autophagy in PC12 cells through decreasing ROS production. Cell Prolif. 2018;51:e12427.","journal-title":"Cell Prolif"},{"key":"2600_CR89","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3233\/JAD-181184","volume":"68","author":"AL Orr","year":"2019","unstructured":"Orr AL, Kim C, Jimenez-Morales D, Newton BW, Johnson JR, Krogan NJ, et al. Neuronal apolipoprotein E4 expression results in proteome-wide alterations and compromises bioenergetic capacity by disrupting mitochondrial function. J Alzheimers Dis. 2019;68:991\u20131011.","journal-title":"J Alzheimers Dis"},{"key":"2600_CR90","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/pcn.13704","volume":"78","author":"XT Liu","year":"2024","unstructured":"Liu XT, Chen X, Zhao N, Geng F, Zhu MM, Ren QG. Synergism of ApoE4 and systemic infectious burden is mediated by the APOE-NLRP3 axis in Alzheimer\u2019s disease. Psychiatry Clin Neurosci. 2024;78:517\u201326.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2600_CR91","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/antiox9080743","volume":"9","author":"DSA Simpson","year":"2020","unstructured":"Simpson DSA, Oliver PL. ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxid (Basel). 2020;9:743.","journal-title":"Antioxid (Basel)"},{"key":"2600_CR92","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fnagi.2020.00252","volume":"12","author":"I Agrawal","year":"2020","unstructured":"Agrawal I, Jha S. Mitochondrial dysfunction and Alzheimer\u2019s disease: role of microglia. Front Aging Neurosci. 2020;12:252.","journal-title":"Front Aging Neurosci"},{"key":"2600_CR93","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1471-4159.2011.07572.x","volume":"120","author":"SH Choi","year":"2012","unstructured":"Choi SH, Aid S, Kim HW, Jackson SH, Bosetti F. Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J Neurochem. 2012;120:292\u2013301.","journal-title":"J Neurochem"},{"key":"2600_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58422-8","volume":"10","author":"L Geng","year":"2020","unstructured":"Geng L, Fan LM, Liu F, Smith C, Li J-. Nox2 dependent redox-regulation of microglial response to amyloid-\u03b2 stimulation and microgliosis in aging. Sci Rep. 2020;10:1582.","journal-title":"Sci Rep"},{"key":"2600_CR95","unstructured":"Kloske CM. Uncovering the Role of ApoE4 on Alzheimer\u2019s Disease-related Neuroinflammation [dissertation]. University of Kentucky (2021)."},{"key":"2600_CR96","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cbin.10975","volume":"43","author":"C Li","year":"2019","unstructured":"Li C, Zhao B, Lin C, Gong Z, An X. TREM2 inhibits inflammatory responses in mouse microglia by suppressing the PI3K\/NF-\u03baB signaling. Cell Biol Int. 2019;43:360\u201372.","journal-title":"Cell Biol Int"},{"key":"2600_CR97","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1096\/fj.14-262683","volume":"29","author":"X Li","year":"2015","unstructured":"Li X, Montine KS, Keene CD, Montine TJ. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia. FASEB J. 2015;29:1754\u201362.","journal-title":"FASEB J"},{"key":"2600_CR98","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, et al. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron. 2020;105:837\u201354.e9.","journal-title":"Neuron"},{"key":"2600_CR99","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw J, Qian L, Pipalia NH, Chao MJ, Liang SA, Shi Y, et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell. 2022;185:2213\u201333.e25.","journal-title":"Cell"},{"key":"2600_CR100","doi-asserted-by":"crossref","unstructured":"Kumari S, Dhapola R, Sharma P, Singh SK, Reddy DH Implicative role of Cytokines in Neuroinflammation mediated AD and associated signaling pathways: current Progress in molecular signaling and therapeutics. Ageing Res Rev. 2023:102098.","DOI":"10.1016\/j.arr.2023.102098"},{"key":"2600_CR101","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"2600_CR102","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz4564","volume":"13","author":"G Sienski","year":"2021","unstructured":"Sienski G, Narayan P, Bonner JM, Kory N, Boland S, Arczewska AA, et al. APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Sci Transl Med. 2021;13:eaaz4564.","journal-title":"Sci Transl Med"},{"key":"2600_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi G, Mi Y, Shi X, Gu H, Brinton RD, Yin F. ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism. Cell Rep. 2021;34:108572.","journal-title":"Cell Rep"},{"key":"2600_CR104","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/1873-3468.12691","volume":"591","author":"YH Kwon","year":"2017","unstructured":"Kwon YH, Kim J, Kim CS, Tu TH, Kim MS, Suk K, et al. Hypothalamic lipid-laden astrocytes induce microglia migration and activation. FEBS Lett. 2017;591:1742\u201351.","journal-title":"FEBS Lett"},{"key":"2600_CR105","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2174\/1567205017666201127163018","volume":"17","author":"A Villarejo-Galende","year":"2020","unstructured":"Villarejo-Galende A, Gonz\u00e1lez-S\u00e1nchez M, Blanco-Palmero VA, Llamas-Velasco S, Benito-Le\u00f3n J. Non-Steroidal Anti-inflammatory Drugs as Candidates for the Prevention Or Treatment of Alzheimer\u2019s disease: do they still have a role?. Curr Alzheimer Res. 2020;17:1013\u201322.","journal-title":"Curr Alzheimer Res"},{"key":"2600_CR106","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jare.2024.03.014","volume":"69","author":"Z Zou","year":"2025","unstructured":"Zou Z, Wu F, Chen L, Yao H, Wang Z, Chen Y, et al. The J bs-5YP peptide can alleviate dementia in senile mice by restoring the transcription of Slc40a1 to secrete the excessive iron from brain. J Adv Res. 2025;69:51\u20139.","journal-title":"J Adv Res"},{"key":"2600_CR107","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s13346-018-0579-4","volume":"9","author":"Z Zou","year":"2019","unstructured":"Zou Z, Shen Q, Pang Y, Li X, Chen Y, Wang X, et al. The synthesized transporter K16APoE enabled the therapeutic HAYED peptide to cross the blood-brain barrier and remove excess iron and radicals in the brain, thus easing Alzheimer\u2019s disease. Drug Deliv Transl Res. 2019;9:394\u2013403.","journal-title":"Drug Deliv Transl Res"},{"key":"2600_CR108","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000508054","volume":"75","author":"P Steiner","year":"2019","unstructured":"Steiner P. Brain fuel utilization in the developing brain. Ann Nutr Metab. 2019;75:8\u201318.","journal-title":"Ann Nutr Metab"},{"key":"2600_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101795","volume":"22","author":"MD Paranjpe","year":"2019","unstructured":"Paranjpe MD, Chen X, Liu M, Paranjpe I, Leal JP, Wang R, et al. The effect of ApoE \u03b54 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study. Neuroimage Clin. 2019;22:101795.","journal-title":"Neuroimage Clin"},{"key":"2600_CR110","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.neurobiolaging.2014.03.006","volume":"35","author":"DS Knopman","year":"2014","unstructured":"Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, et al. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Neurobiol Aging. 2014;35:2096\u2013106.","journal-title":"Neurobiol Aging"},{"key":"2600_CR111","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao N, Liu CC, Van Ingelgom AJ, Martens YA, Linares C, Knight JA, et al. Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron. 2017;96:115\u201329.e5.","journal-title":"Neuron"},{"key":"2600_CR112","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1523\/JNEUROSCI.2262-17.2018","volume":"38","author":"L Wu","year":"2018","unstructured":"Wu L, Zhang X, Zhao L. Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer\u2019s disease risk reduction and early intervention. J Neurosci. 2018;38:6665\u201381.","journal-title":"J Neurosci"},{"key":"2600_CR113","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/JAD-151205","volume":"53","author":"M Perkins","year":"2016","unstructured":"Perkins M, Wolf AB, Chavira B, Shonebarger D, Meckel JP, Leung L, et al. Altered energy metabolism pathways in the posterior cingulate in young adult apolipoprotein E \u025b4 carriers. J Alzheimers Dis. 2016;53:95\u2013106.","journal-title":"J Alzheimers Dis"},{"key":"2600_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1122300","volume":"15","author":"J Huang","year":"2023","unstructured":"Huang J, Huang N, Cui D, Shi J, Qiu Y. Clinical antidiabetic medication used in Alzheimer\u2019s disease: From basic discovery to therapeutics development. Front Aging Neurosci. 2023;15:1122300.","journal-title":"Front Aging Neurosci"},{"key":"2600_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104742","volume":"136","author":"HC Williams","year":"2020","unstructured":"Williams HC, Farmer BC, Piron MA, Walsh AE, Bruntz RC, Gentry MS, et al. APOE alters glucose flux through central carbon pathways in astrocytes. Neurobiol Dis. 2020;136:104742.","journal-title":"Neurobiol Dis"},{"key":"2600_CR116","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/alz.12845","volume":"19","author":"HN Yassine","year":"2023","unstructured":"Yassine HN, Self W, Kerman BE, Santoni G, Navalpur Shanmugam N, Abdullah L, et al. Nutritional metabolism and cerebral bioenergetics in Alzheimer\u2019s disease and related dementias. Alzheimers Dement. 2023;19:1041\u201366.","journal-title":"Alzheimers Dement"},{"key":"2600_CR117","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12986-022-00687-z","volume":"19","author":"X Xue","year":"2022","unstructured":"Xue X, Liu B, Hu J, Bian X, Lou S. The potential mechanisms of lactate in mediating exercise-enhanced cognitive function: a dual role as an energy supply substrate and a signaling molecule. Nutr Metab (Lond). 2022;19:52.","journal-title":"Nutr Metab (Lond)"},{"key":"2600_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113183","volume":"42","author":"H Lee","year":"2023","unstructured":"Lee H, Cho S, Kim MJ, Park YJ, Cho E, Jo YS, et al. ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes. Cell Rep. 2023;42:113183.","journal-title":"Cell Rep"},{"key":"2600_CR119","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neurobiolaging.2020.12.007","volume":"101","author":"Y Decker","year":"2021","unstructured":"Decker Y, N\u00e9meth E, Schomburg R, Chemla A, F\u00fcl\u00f6p L, Menger MD, et al. Decreased pH in the aging brain and Alzheimer\u2019s disease. Neurobiol Aging. 2021;101:40\u20139.","journal-title":"Neurobiol Aging"},{"key":"2600_CR120","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","volume":"290","author":"F Yin","year":"2023","unstructured":"Yin F. Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J. 2023;290:1420\u201353.","journal-title":"FEBS J"},{"key":"2600_CR121","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cmet.2024.03.014","volume":"36","author":"Y Li","year":"2024","unstructured":"Li Y, Munoz-Mayorga D, Nie Y, Kang N, Tao Y, Lagerwall J, et al. Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK. Cell Metab. 2024;36:1351\u201370.e8.","journal-title":"Cell Metab"},{"key":"2600_CR122","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","volume":"177","author":"MS Ioannou","year":"2019","unstructured":"Ioannou MS, Jackson J, Sheu SH, Chang CL, Weigel AV, Liu H, et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell. 2019;177:1522\u201335.e14.","journal-title":"Cell"},{"key":"2600_CR123","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","volume":"26","author":"L Liu","year":"2017","unstructured":"Liu L, MacKenzie KR, Putluri N, Maleti\u0107-Savati\u0107 M, Bellen HJ. The glia-neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D. Cell Metab. 2017;26:719\u201337.e6.","journal-title":"Cell Metab"},{"key":"2600_CR124","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fncel.2019.00212","volume":"13","author":"CN Barber","year":"2019","unstructured":"Barber CN, Raben DM. Lipid metabolism crosstalk in the brain: glia and neurons. Front Cell Neurosci. 2019;13:212.","journal-title":"Front Cell Neurosci"},{"key":"2600_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01881-6","volume":"12","author":"AM Miranda","year":"2022","unstructured":"Miranda AM, Ashok A, Chan RB, Zhou B, Xu Y, McIntire LB, et al. Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice. Transl Psychiatry. 2022;12:129.","journal-title":"Transl Psychiatry"},{"key":"2600_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01444-0","volume":"8","author":"T Nuriel","year":"2017","unstructured":"Nuriel T, Angulo SL, Khan U, Ashok A, Chen Q, Figueroa HY, et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology. Nat Commun. 2017;8:1464.","journal-title":"Nat Commun"},{"key":"2600_CR127","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","volume":"29","author":"MB Victor","year":"2022","unstructured":"Victor MB, Leary N, Luna X, Meharena HS, Scannail AN, Bozzelli PL, et al. Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. Cell Stem Cell. 2022;29:1197\u2013212.e8.","journal-title":"Cell Stem Cell"},{"key":"2600_CR128","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;611:769\u201379.","journal-title":"Nature"},{"key":"2600_CR129","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s12276-023-00935-z","volume":"55","author":"C Wang","year":"2023","unstructured":"Wang C, Lu J, Sha X, Qiu Y, Chen H, Yu Z. TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia. Exp Mol Med. 2023;55:347\u201363.","journal-title":"Exp Mol Med"},{"key":"2600_CR130","doi-asserted-by":"publisher","first-page":"BSR20171611","DOI":"10.1042\/BSR20171611","volume":"38","author":"CS Lim","year":"2018","unstructured":"Lim CS, Han JS. The antioxidant xanthorrhizol prevents amyloid-\u03b2-induced oxidative modification and inactivation of neprilysin. Biosci Rep. 2018;38:BSR20171611.","journal-title":"Biosci Rep"},{"key":"2600_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101283","volume":"26","author":"C de Dios","year":"2019","unstructured":"de Dios C, Bartolessis I, Roca-Agujetas V, Barbero-Camps E, Mari M, Morales A, et al. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress. Redox Biol. 2019;26:101283.","journal-title":"Redox Biol"},{"key":"2600_CR132","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2174\/1567205014666170317113606","volume":"14","author":"C Domingues","year":"2017","unstructured":"Domingues C, da Cruz E Silva OAB, Henriques AG. Impact of cytokines and chemokines on Alzheimer\u2019s disease neuropathological Hallmarks. Curr Alzheimer Res. 2017;14:870\u201382.","journal-title":"Curr Alzheimer Res"},{"key":"2600_CR133","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/glycob\/cwaa011","volume":"30","author":"F Cheng","year":"2020","unstructured":"Cheng F, Fransson L\u00c5, Mani K. Proinflammatory cytokines induce accumulation of glypican-1-derived heparan sulfate and the C-terminal fragment of \u03b2-cleaved APP in autophagosomes of dividing neuronal cells. Glycobiology. 2020;30:539\u201349.","journal-title":"Glycobiology"},{"key":"2600_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/srep03754","volume":"4","author":"QR Ong","year":"2014","unstructured":"Ong QR, Chan ES, Lim ML, Cole GM, Wong BS. Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice. Sci Rep. 2014;4:3754.","journal-title":"Sci Rep"},{"key":"2600_CR135","doi-asserted-by":"publisher","first-page":"E1230","DOI":"10.1073\/pnas.1320192111","volume":"111","author":"G Joshi","year":"2014","unstructured":"Joshi G, Chi Y, Huang Z, Wang Y. A\u03b2-induced Golgi fragmentation in Alzheimer\u2019s disease enhances A\u03b2 production. Proc Natl Acad Sci USA. 2014;111:E1230\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2600_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02567-y","volume":"19","author":"Y Dong","year":"2022","unstructured":"Dong Y, Yu H, Li X, Bian K, Zheng Y, Dai M, et al. Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer\u2019s disease. J Neuroinflammation. 2022;19:205.","journal-title":"J Neuroinflammation"},{"key":"2600_CR137","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/JAD-190588","volume":"77","author":"KR Hollinger","year":"2020","unstructured":"Hollinger KR, Zhu X, Khoury ES, Thomas AG, Liaw K, Tallon C, et al. Glutamine antagonist JHU-083 normalizes aberrant hippocampal glutaminase activity and improves cognition in APOE4 Mice. J Alzheimers Dis. 2020;77:437\u201347.","journal-title":"J Alzheimers Dis"},{"key":"2600_CR138","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/cells12030410","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wu L, Swerdlow RH, Zhao L. Opposing effects of ApoE2 and ApoE4 on glycolytic metabolism in neuronal aging supports a warburg neuroprotective cascade against Alzheimer\u2019s disease. Cells. 2023;12:410.","journal-title":"Cells"},{"key":"2600_CR139","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JAD-160467","volume":"54","author":"A Boehm-Cagan","year":"2016","unstructured":"Boehm-Cagan A, Bar R, Liraz O, Bielicki JK, Johansson JO, Michaelson DM. ABCA1 agonist reverses the ApoE4-driven cognitive and brain pathologies. J Alzheimers Dis. 2016;54:1219\u201333.","journal-title":"J Alzheimers Dis"},{"key":"2600_CR140","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-025-00802-7","volume":"20","author":"S Wang","year":"2025","unstructured":"Wang S, Li B, Li J, Cai Z, Hugo C, Sun Y, et al. Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD. Mol Neurodegener. 2025;20:15.","journal-title":"Mol Neurodegener"},{"key":"2600_CR141","doi-asserted-by":"publisher","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova R, Staufenbiel M, Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem. 2005;280:43224\u201335. Dec 30.","journal-title":"J Biol Chem"},{"key":"2600_CR142","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, et al. Two randomized phase 3 studies of aducanumab in Early Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2022;9:197\u2013210.","journal-title":"J Prev Alzheimers Dis"},{"key":"2600_CR143","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.14283\/jpad.2024.106","volume":"11","author":"Y Toda","year":"2024","unstructured":"Toda Y, Iwatsubo T, Nakamura Y, Matsuda N, Miyata M, Jin M, et al. Japanese subgroup analyses from EMERGE and ENGAGE, phase 3 clinical trials of aducanumab in patients with early Alzheimer\u2019s Disease. J Prev Alzheimers Dis. 2024;11:1260\u20139.","journal-title":"J Prev Alzheimers Dis"},{"key":"2600_CR144","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"2600_CR145","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","volume":"389","author":"RA Sperling","year":"2023","unstructured":"Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, et al. Trial of solanezumab in preclinical Alzheimer\u2019s disease. N Engl J Med. 2023;389:1096\u2013107.","journal-title":"N Engl J Med"},{"key":"2600_CR146","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jamaneurol.2022.2909","volume":"79","author":"S Ostrowitzki","year":"2022","unstructured":"Ostrowitzki S, Bittner T, Sink KM, Mackey H, Rabe C, Honig LS, et al. Evaluating the safety and efficacy of crenezumab vs placebo in adults with early Alzheimer disease: two phase 3 randomized placebo-controlled trials. JAMA Neurol. 2022;79:1113\u201321.","journal-title":"JAMA Neurol"},{"key":"2600_CR147","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S1474-4422(25)00024-9","volume":"24","author":"RJ Bateman","year":"2025","unstructured":"Bateman RJ, Li Y, McDade EM, Llibre-Guerra JJ, Clifford DB, Atri A, et al. Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer\u2019s disease: an open-label extension of the phase 2\/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. Lancet Neurol. 2025;24:316\u201330.","journal-title":"Lancet Neurol"},{"key":"2600_CR148","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3233\/JAD-150376","volume":"51","author":"F Pasquier","year":"2016","unstructured":"Pasquier F, Sadowsky C, Holstein A, Leterme GleP, Peng Y, Jackson N, et al. Two phase 2 multiple ascending-dose studies of vanutide cridificar (ACC-001) and QS-21 adjuvant in mild-to-moderate Alzheimer\u2019s disease. J Alzheimers Dis. 2016;51:1131\u201343.","journal-title":"J Alzheimers Dis"},{"key":"2600_CR149","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2174\/1567205014666170117101537","volume":"14","author":"M Hull","year":"2017","unstructured":"Hull M, Sadowsky C, Arai H, Le Prince Leterme G, Holstein A, Booth K, et al. Long-term extensions of randomized vaccination trials of ACC-001 and QS-21 in mild to moderate Alzheimer\u2019s disease. Curr Alzheimer Res. 2017;14:696\u2013708.","journal-title":"Curr Alzheimer Res"},{"key":"2600_CR150","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1124\/jpet.114.219352","volume":"352","author":"TC Baddeley","year":"2015","unstructured":"Baddeley TC, McCaffrey J, Storey JM, Cheung JK, Melis V, Horsley D, et al. Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer\u2019s disease. J Pharm Exp Ther. 2015;352:110\u20138.","journal-title":"J Pharm Exp Ther"},{"key":"2600_CR151","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3233\/JAD-170560","volume":"61","author":"GK Wilcock","year":"2018","unstructured":"Wilcock GK, Gauthier S, Frisoni GB, Jia J, Hardlund JH, Moebius HJ, et al. Potential of low dose leuco-methylthioninium bis(hydromethanesulphonate) (LMTM) monotherapy for treatment of mild Alzheimer\u2019s disease: cohort analysis as modified primary outcome in a phase III clinical trial. J Alzheimers Dis. 2018;61:435\u201357.","journal-title":"J Alzheimers Dis"},{"key":"2600_CR152","doi-asserted-by":"publisher","first-page":"780","DOI":"10.14283\/jpad.2022.63","volume":"9","author":"CM Wischik","year":"2022","unstructured":"Wischik CM, Bentham P, Gauthier S, Miller S, Kook K, Schelter BO. Oral tau aggregation inhibitor for alzheimer\u2019s disease: design, progress and basis for selection of the 16 mg\/day dose in a phase 3, randomized, placebo-controlled trial of hydromethylthionine mesylate. J Prev Alzheimers Dis. 2022;9:780\u201390.","journal-title":"J Prev Alzheimers Dis"},{"key":"2600_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14414","volume":"21","author":"T Bittner","year":"2025","unstructured":"Bittner T, Tonietto M, Klein G, Belusov A, Illiano V, Voyle N, et al. Biomarker treatment effects in two phase 3 trials of gantenerumab. Alzheimers Dement. 2025;21:e14414.","journal-title":"Alzheimers Dement"},{"key":"2600_CR154","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","volume":"27","author":"S Salloway","year":"2021","unstructured":"Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer\u2019s disease. Nat Med. 2021;27:1187\u201396.","journal-title":"Nat Med"},{"key":"2600_CR155","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/jamaneurol.2019.3812","volume":"77","author":"RM Tsai","year":"2020","unstructured":"Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, et al. Reactions to multiple ascending doses of the microtubule stabilizer TPI-287 in patients with alzheimer disease, progressive supranuclear palsy, and corticobasal syndrome: a randomized clinical trial. JAMA Neurol. 2020;77:215\u201324.","journal-title":"JAMA Neurol"},{"key":"2600_CR156","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/brain\/awad024","volume":"146","author":"H Florian","year":"2023","unstructured":"Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z, et al. Tilavonemab in early Alzheimer\u2019s disease: results from a phase 2, randomized, double-blind study. Brain. 2023;146:2275\u201384.","journal-title":"Brain"},{"key":"2600_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19227-5","volume":"11","author":"A McQuade","year":"2020","unstructured":"McQuade A, Kang YJ, Hasselmann J, Jairaman A, Sotelo A, Coburn M, et al. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease. Nat Commun. 2020;11:5370.","journal-title":"Nat Commun"},{"key":"2600_CR158","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1093\/hmg\/ddaa179","volume":"29","author":"A Griciuc","year":"2020","unstructured":"Griciuc A, Federico AN, Natasan J, Forte AM, McGinty D, Nguyen H, et al. Gene therapy for Alzheimer\u2019s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Hum Mol Genet. 2020;29:2920\u201335.","journal-title":"Hum Mol Genet"},{"key":"2600_CR159","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1007\/s12035-020-01982-7","volume":"57","author":"Y He","year":"2020","unstructured":"He Y, Ruganzu JB, Zheng Q, Wu X, Jin H, Peng X, et al. Silencing of LRP1 exacerbates inflammatory response Via TLR4\/NF-\u03baB\/MAPKs signaling pathways in APP\/PS1 transgenic mice. Mol Neurobiol. 2020;57:3727\u201343.","journal-title":"Mol Neurobiol"},{"key":"2600_CR160","first-page":"2788","volume":"21","author":"A Imraish","year":"2023","unstructured":"Imraish A, Abu-Thiab T, Hammad H. P2X and P2Y receptor antagonists reduce inflammation in ATP-induced microglia. Pharm Pr (Granada). 2023;21:2788.","journal-title":"Pharm Pr (Granada)"},{"key":"2600_CR161","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/14728222.2019.1676416","volume":"23","author":"GR Leitner","year":"2019","unstructured":"Leitner GR, Wenzel TJ, Marshall N, Gates EJ, Klegeris A. Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders. Expert Opin Ther Targets. 2019;23:865\u201382.","journal-title":"Expert Opin Ther Targets"},{"key":"2600_CR162","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41422-022-00759-y","volume":"33","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wang Y, Huang G, Yang M, Zhu Y, Jin C, et al. LilrB3 is a putative cell surface receptor of APOE4. Cell Res. 2023;33:116\u201330.","journal-title":"Cell Res"},{"key":"2600_CR163","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1007\/s11064-017-2321-x","volume":"42","author":"C Shen","year":"2017","unstructured":"Shen C, Ma Y, Zeng Z, Yin Q, Hong Y, Hou X, et al. RAGE-specific inhibitor FPS-ZM1 attenuates AGEs-induced neuroinflammation and oxidative stress in rat primary microglia. Neurochem Res. 2017;42:2902\u201311.","journal-title":"Neurochem Res"},{"key":"2600_CR164","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuroscience.2020.11.003","volume":"453","author":"AM Dobri","year":"2021","unstructured":"Dobri AM, Dud\u0103u M, Enciu AM, Hinescu ME. CD36 in Alzheimer\u2019s disease: an overview of molecular mechanisms and therapeutic targeting. Neuroscience. 2021;453:301\u201311.","journal-title":"Neuroscience"},{"key":"2600_CR165","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.3390\/ijms22073330","volume":"22","author":"M Eshraghi","year":"2021","unstructured":"Eshraghi M, Adlimoghaddam A, Mahmoodzadeh A, Sharifzad F, Yasavoli-Sharahi H, Lorzadeh S, et al. Alzheimer\u2019s disease pathogenesis: role of autophagy and mitophagy focusing in microglia. Int J Mol Sci. 2021;22:3330.","journal-title":"Int J Mol Sci"},{"key":"2600_CR166","doi-asserted-by":"publisher","first-page":"992","DOI":"10.15252\/emmm.201606370","volume":"8","author":"X Xiang","year":"2016","unstructured":"Xiang X, Werner G, Bohrmann B, Liesz A, Mazaheri F, Capell A, et al. TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance. EMBO Mol Med. 2016;8:992\u20131004.","journal-title":"EMBO Mol Med"},{"key":"2600_CR167","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/glia.23757","volume":"68","author":"DH Allendorf","year":"2020","unstructured":"Allendorf DH, Puigdell\u00edvol M, Brown GC. Activated microglia desialylate their surface, stimulating complement receptor 3-mediated phagocytosis of neurons. Glia. 2020;68:989\u201398.","journal-title":"Glia"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02600-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T03:29:54Z","timestamp":1751945394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02600-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":167,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2600"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02600-y","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}